About
The University of Turku is an international science university which creates innovation for the future, well-being, and knowledge through multidisciplinary research and education. The Department of Pediatrics involved in SynAir-G has a long tradition of carrying out translational long-term follow-up studies investigating how environmental factors affect health.
Role in the project
The University of Turku is one of the clinical centres which will collect indoor air and clinical data from schools. We aim to recruit 700 pupils from four schools within 2 years. The cohort is enriched by 200 pupils suffering from allergies or asthma. Diverse sampling includes air quality and environmental data, biological samples, pulmonary function data, registry data and health and quality of life questionnaires.
Tuomas Jartti, Professor of Pediatrics, Pediatrician, Pediatric allergist
Prof. Jartti’s research focuses on the early stages of childhood asthma, allergic inflammation and respiratory virus infections. In SynAir-G, he leads the clinical study centre in Turku and in the IDEAL cluster he leads WG6, Clinical Outcomes.
Varpu Elenius, University lecturer, Pediatrician, Pediatric allergist
Dr Elenius’s research focuses on the early stages of childhood asthma, severe asthma and chronic lung diseases. In SynAir-G, she works as a senior scientist in the clinical study centre of Turku, as well as in the IDEAL cluster in WG6, Clinical Outcomes.
Maria Hartiala, Post-doc researcher, Pediatrician, and Resident in pediatric allergology
Dr Hartiala’s research focuses on the early stages of childhood asthma and respiratory virus and bacterial infections. In SynAir-G, she works as a junior scientist in the clinical study centre of Turku and in the IDEAL cluster in WG6, Clinical Outcomes.
Olli Jartti, Student in mechanical engineering (medical)
Olli Jartti’s interests are in medical engineering, both soft- and hardware. In SynAir-G, he works as a technical assistant in the clinical study centre of Turku, as well as in the IDEAL cluster in WG6, Clinical Outcomes.